Facebook
Twitter
LinkedIn
Forward
Virtual 5th Annual Conference on Psychedelics and Psychedelic Medicine
We invite you to join us Virtually for our 5th Annual Conference on Psychedelics and Psychedelic Medicine!
Please Note: The conference will be held in Eastern Daylight Time (EDT)
This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, and psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.
You will receive an email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the zoom instructions and attending virtually.
Pricing
MDs/Doctoral-Level Professionals:
Super Early Bird (on or before August 15, 2025): $475.00
Early Bird (on or before October 3, 2025): $525.00
Regular Registration (after October 3, 2025): $550.00
Other Clinicians:
Super Early Bird (on or before August 15, 2025): $350.00
Early Bird (on or before October 3, 2025): $400.00
Regular Registration (after October 3, 2025): $425.00
Other Professionals: $150.00
Trainees/Students: $100.00
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Livestream Troubleshooting Tips.pdf
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 3, 2025. No refunds will be issued for refund requests made after October 3, 2025. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Target Audience
This program is designed for clinicians and researchers across various disciplines who are interested in deepening their understanding of psychedelics, both theoretically and practically. It is open to mental health practitioners such as psychiatrists, psychiatric nurse practitioners, social workers, and clinical psychologists, as well as professionals from other fields who are curious about the applications of psychedelics in clinical and research settings.
Accreditation
Accreditation is under review. Please check back soon.
Learning Objectives
By the end of this program, participants will be able to:
- Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
- Explain the neuropsychopharmacology of classical psychedelics as well as atypical psychedelics such as ketamine and empathogens such as MDMA
- Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
- Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice
- Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation
Agenda Not Available Yet. Please check back soon for the program agenda.
Course Director:
Franklin King, MD
Speakers:
Please check back soon for the faculty speaker list.